August 15 - 18, 2017
Palais du Grand Large, Saint Malo, France
Meet with Flagship at the 22nd International Annual Congress of the World Muscle Society to discover how we help drug developers define their path to success. Our computational Tissue Analysis (cTA™) approach provides the quantitative, contextual data needed to make confident clinical trials decisions. We partner with drug developers to implement tissue-based biomarker strategies and drive efficient and effective clinical trials.
Look for the three scientific posters featuring Flagship’s work at this important conference. Reach out to a member of our team to discuss your needs in clinical trial decision support in muscle-based disease areas.